A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...

Prademagene zamikeracel, a gene-modified treatment applied surgically, was seen to increase wound healing and pain in RDEB.

Young patients with atopic dermatitis prioritize different treatment goals and have varying preferences from their caregivers.

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.

[A]lthough our findings found that there is insufficient evidence to suggest that dupilumab use is associated with joint pain, the prevalence of joint pain observed among patients treated with ...

A survey of more than 20,000 patients revealed a lack of trust in information about cancer, whether it comes from scientists, ...

Insurance companies pledged to reduce wait times for prior authorization approvals, with support from Dr Mehmet Oz.

Here's a new summary of all the drugs in the pipeline currently being evaluated for the treatments of vasculitis.

Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in ...

By including information on suicidal thoughts and behaviors, clinicians can greatly improve predictive accuracy via machine learning.

Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

Children of various racial and ethnic minority groups have a higher prevalence of alopecia areata than non-Hispanic White children.